Bhadhuri, Arjun
Dröschel, Daniel
Guldimann, Mike
Jetschgo, Claudia
Banhazi, Judit
Schwenkglenks, Matthias
Sutherland, C. Simone
Funding for this research was provided by:
Novartis
Article History
Received: 14 January 2022
Accepted: 17 June 2022
First Online: 28 June 2022
Declarations
:
: Not applicable
: Not applicable
: CJ is an employee of Novartis Pharma Schweiz AG. JB is an employee of Novartis Pharma AG. MS receives grants, via employment institution, from Novartis. CSS has received funding via contracted consulting services from Vifor Pharma, Mitsubishi Tanabe Pharma and F. Hoffman La-Roche. Rest of the authors have no Conflict of interest to declare.